nodes	percent_of_prediction	percent_of_DWPC	metapath
Metipranolol—Propranolol—migraine	0.444	1	CrCtD
Metipranolol—ADRB2—Timolol—migraine	0.0574	0.266	CbGbCtD
Metipranolol—ADRB1—Timolol—migraine	0.0566	0.262	CbGbCtD
Metipranolol—ADRB2—Propranolol—migraine	0.0512	0.237	CbGbCtD
Metipranolol—ADRB1—Propranolol—migraine	0.0504	0.234	CbGbCtD
Metipranolol—Acebutolol—Propranolol—migraine	0.0427	0.153	CrCrCtD
Metipranolol—Metoprolol—Propranolol—migraine	0.0352	0.126	CrCrCtD
Metipranolol—Alprenolol—Propranolol—migraine	0.0352	0.126	CrCrCtD
Metipranolol—Practolol—Propranolol—migraine	0.0352	0.126	CrCrCtD
Metipranolol—Oxprenolol—Propranolol—migraine	0.0352	0.126	CrCrCtD
Metipranolol—Atenolol—Propranolol—migraine	0.0333	0.12	CrCrCtD
Metipranolol—Esmolol—Propranolol—migraine	0.0316	0.114	CrCrCtD
Metipranolol—Pindolol—Propranolol—migraine	0.0301	0.108	CrCrCtD
Metipranolol—ADRB1—Endothelin Pathways—RAMP1—migraine	0.00106	0.0401	CbGpPWpGaD
Metipranolol—ADRB1—Endothelin Pathways—CALCRL—migraine	0.00106	0.0401	CbGpPWpGaD
Metipranolol—ADRB1—Monoamine GPCRs—HTR1D—migraine	0.000774	0.0291	CbGpPWpGaD
Metipranolol—ADRB2—Monoamine GPCRs—HTR1D—migraine	0.000757	0.0285	CbGpPWpGaD
Metipranolol—ADRB1—Monoamine GPCRs—HTR2B—migraine	0.000719	0.0271	CbGpPWpGaD
Metipranolol—ADRB2—Monoamine GPCRs—HTR2B—migraine	0.000704	0.0265	CbGpPWpGaD
Metipranolol—Lacrimation—Timolol—migraine	0.000676	0.0198	CcSEcCtD
Metipranolol—ADRB1—Amine ligand-binding receptors—HTR1D—migraine	0.00065	0.0245	CbGpPWpGaD
Metipranolol—Blepharitis—Timolol—migraine	0.000646	0.0189	CcSEcCtD
Metipranolol—ADRB2—Amine ligand-binding receptors—HTR1D—migraine	0.000636	0.0239	CbGpPWpGaD
Metipranolol—Arthritis—Amitriptyline—migraine	0.000628	0.0184	CcSEcCtD
Metipranolol—ADRB1—Amine ligand-binding receptors—HTR2B—migraine	0.000605	0.0228	CbGpPWpGaD
Metipranolol—ADRB2—Amine ligand-binding receptors—HTR2B—migraine	0.000591	0.0223	CbGpPWpGaD
Metipranolol—ADRB1—Monoamine GPCRs—HTR1B—migraine	0.000469	0.0176	CbGpPWpGaD
Metipranolol—Acute coronary syndrome—Amitriptyline—migraine	0.000464	0.0136	CcSEcCtD
Metipranolol—Myocardial infarction—Amitriptyline—migraine	0.000461	0.0135	CcSEcCtD
Metipranolol—ADRB2—Monoamine GPCRs—HTR1B—migraine	0.000459	0.0173	CbGpPWpGaD
Metipranolol—ADRB1—Monoamine GPCRs—HTR1A—migraine	0.000451	0.017	CbGpPWpGaD
Metipranolol—ADRB2—Monoamine GPCRs—HTR1A—migraine	0.000441	0.0166	CbGpPWpGaD
Metipranolol—ADRB1—Monoamine GPCRs—HTR2C—migraine	0.000436	0.0164	CbGpPWpGaD
Metipranolol—Lacrimation increased—Timolol—migraine	0.000431	0.0126	CcSEcCtD
Metipranolol—ADRB2—Monoamine GPCRs—HTR2C—migraine	0.000426	0.016	CbGpPWpGaD
Metipranolol—ADRB1—Endothelin Pathways—EDNRA—migraine	0.000424	0.016	CbGpPWpGaD
Metipranolol—Photophobia—Valproic Acid—migraine	0.000419	0.0123	CcSEcCtD
Metipranolol—Bronchitis—Propranolol—migraine	0.000413	0.0121	CcSEcCtD
Metipranolol—ADRB1—Endothelin Pathways—CALCA—migraine	0.000408	0.0154	CbGpPWpGaD
Metipranolol—Lacrimation increased—Gabapentin—migraine	0.000402	0.0118	CcSEcCtD
Metipranolol—ADRB1—Amine ligand-binding receptors—HTR1B—migraine	0.000394	0.0148	CbGpPWpGaD
Metipranolol—Abnormal vision—Valproic Acid—migraine	0.000389	0.0114	CcSEcCtD
Metipranolol—ADRB2—Amine ligand-binding receptors—HTR1B—migraine	0.000385	0.0145	CbGpPWpGaD
Metipranolol—Angina pectoris—Verapamil—migraine	0.000385	0.0113	CcSEcCtD
Metipranolol—ADRB1—Monoamine GPCRs—HTR7—migraine	0.000382	0.0144	CbGpPWpGaD
Metipranolol—ADRB1—Amine ligand-binding receptors—HTR1A—migraine	0.000379	0.0143	CbGpPWpGaD
Metipranolol—ADRB2—Monoamine GPCRs—HTR7—migraine	0.000373	0.0141	CbGpPWpGaD
Metipranolol—Photophobia—Timolol—migraine	0.000373	0.0109	CcSEcCtD
Metipranolol—ADRB2—Amine ligand-binding receptors—HTR1A—migraine	0.000371	0.014	CbGpPWpGaD
Metipranolol—ADRB1—G alpha (s) signalling events—CALCRL—migraine	0.000369	0.0139	CbGpPWpGaD
Metipranolol—ADRB1—G alpha (s) signalling events—RAMP1—migraine	0.000369	0.0139	CbGpPWpGaD
Metipranolol—ADRB1—Amine ligand-binding receptors—HTR2C—migraine	0.000366	0.0138	CbGpPWpGaD
Metipranolol—Pindolol—HTR1B—migraine	0.000365	0.271	CrCbGaD
Metipranolol—ADRB2—G alpha (s) signalling events—CALCRL—migraine	0.000361	0.0136	CbGpPWpGaD
Metipranolol—ADRB2—G alpha (s) signalling events—RAMP1—migraine	0.000361	0.0136	CbGpPWpGaD
Metipranolol—ADRB2—Amine ligand-binding receptors—HTR2C—migraine	0.000358	0.0135	CbGpPWpGaD
Metipranolol—Bradycardia—Propranolol—migraine	0.00035	0.0103	CcSEcCtD
Metipranolol—Photophobia—Gabapentin—migraine	0.000348	0.0102	CcSEcCtD
Metipranolol—Acute coronary syndrome—Verapamil—migraine	0.000347	0.0102	CcSEcCtD
Metipranolol—Abnormal vision—Timolol—migraine	0.000347	0.0102	CcSEcCtD
Metipranolol—Vision blurred—Amitriptyline—migraine	0.000346	0.0102	CcSEcCtD
Metipranolol—Myocardial infarction—Verapamil—migraine	0.000345	0.0101	CcSEcCtD
Metipranolol—Lacrimation increased—Topiramate—migraine	0.000338	0.00991	CcSEcCtD
Metipranolol—Alprenolol—HTR1A—migraine	0.000335	0.249	CrCbGaD
Metipranolol—Visual impairment—Propranolol—migraine	0.000331	0.00971	CcSEcCtD
Metipranolol—Palpitations—Amitriptyline—migraine	0.000325	0.00952	CcSEcCtD
Metipranolol—Abnormal vision—Gabapentin—migraine	0.000323	0.00947	CcSEcCtD
Metipranolol—Bradycardia—Verapamil—migraine	0.000322	0.00944	CcSEcCtD
Metipranolol—ADRB1—Amine ligand-binding receptors—HTR7—migraine	0.000321	0.0121	CbGpPWpGaD
Metipranolol—Hypertension—Amitriptyline—migraine	0.000317	0.0093	CcSEcCtD
Metipranolol—Rhinitis—Verapamil—migraine	0.000317	0.0093	CcSEcCtD
Metipranolol—ADRB2—Amine ligand-binding receptors—HTR7—migraine	0.000314	0.0118	CbGpPWpGaD
Metipranolol—Anxiety—Amitriptyline—migraine	0.000312	0.00914	CcSEcCtD
Metipranolol—Discomfort—Amitriptyline—migraine	0.000309	0.00906	CcSEcCtD
Metipranolol—Visual impairment—Verapamil—migraine	0.000305	0.00894	CcSEcCtD
Metipranolol—Oedema—Amitriptyline—migraine	0.0003	0.0088	CcSEcCtD
Metipranolol—Photophobia—Topiramate—migraine	0.000292	0.00857	CcSEcCtD
Metipranolol—Pindolol—HTR1A—migraine	0.000288	0.215	CrCbGaD
Metipranolol—Atrial fibrillation—Gabapentin—migraine	0.000284	0.00831	CcSEcCtD
Metipranolol—Arthritis—Gabapentin—migraine	0.000276	0.00811	CcSEcCtD
Metipranolol—Abnormal vision—Topiramate—migraine	0.000272	0.00796	CcSEcCtD
Metipranolol—Bronchitis—Valproic Acid—migraine	0.000269	0.0079	CcSEcCtD
Metipranolol—ADRB1—Monoamine GPCRs—HTR2A—migraine	0.000267	0.0101	CbGpPWpGaD
Metipranolol—Somnolence—Amitriptyline—migraine	0.000267	0.00782	CcSEcCtD
Metipranolol—ADRB2—Monoamine GPCRs—HTR2A—migraine	0.000262	0.00984	CbGpPWpGaD
Metipranolol—Cough—Propranolol—migraine	0.000261	0.00766	CcSEcCtD
Metipranolol—Vision blurred—Verapamil—migraine	0.000259	0.00761	CcSEcCtD
Metipranolol—Palpitations—Verapamil—migraine	0.000243	0.00713	CcSEcCtD
Metipranolol—Angina pectoris—Timolol—migraine	0.000243	0.00712	CcSEcCtD
Metipranolol—Conjunctivitis—Valproic Acid—migraine	0.000243	0.00712	CcSEcCtD
Metipranolol—ADRB1—Calcium Regulation in the Cardiac Cell—CACNA1A—migraine	0.000242	0.00909	CbGpPWpGaD
Metipranolol—Hypertension—Verapamil—migraine	0.000238	0.00697	CcSEcCtD
Metipranolol—ADRB2—Calcium Regulation in the Cardiac Cell—CACNA1A—migraine	0.000236	0.0089	CbGpPWpGaD
Metipranolol—Epistaxis—Valproic Acid—migraine	0.000236	0.00691	CcSEcCtD
Metipranolol—Myalgia—Verapamil—migraine	0.000234	0.00687	CcSEcCtD
Metipranolol—Discomfort—Verapamil—migraine	0.000232	0.00679	CcSEcCtD
Metipranolol—Bradycardia—Valproic Acid—migraine	0.000228	0.00669	CcSEcCtD
Metipranolol—Angina pectoris—Gabapentin—migraine	0.000226	0.00663	CcSEcCtD
Metipranolol—Rhinitis—Valproic Acid—migraine	0.000225	0.00659	CcSEcCtD
Metipranolol—ADRB1—Amine ligand-binding receptors—HTR2A—migraine	0.000225	0.00846	CbGpPWpGaD
Metipranolol—Oedema—Verapamil—migraine	0.000225	0.00659	CcSEcCtD
Metipranolol—Bronchitis—Gabapentin—migraine	0.000223	0.00655	CcSEcCtD
Metipranolol—ADRB2—Amine ligand-binding receptors—HTR2A—migraine	0.00022	0.00827	CbGpPWpGaD
Metipranolol—Dyspnoea—Propranolol—migraine	0.000218	0.00638	CcSEcCtD
Metipranolol—Somnolence—Propranolol—migraine	0.000217	0.00637	CcSEcCtD
Metipranolol—Conjunctivitis—Timolol—migraine	0.000216	0.00634	CcSEcCtD
Metipranolol—Visual impairment—Valproic Acid—migraine	0.000216	0.00634	CcSEcCtD
Metipranolol—Asthenia—Amitriptyline—migraine	0.000215	0.00631	CcSEcCtD
Metipranolol—Epistaxis—Timolol—migraine	0.00021	0.00615	CcSEcCtD
Metipranolol—Musculoskeletal discomfort—Verapamil—migraine	0.000205	0.006	CcSEcCtD
Metipranolol—Acute coronary syndrome—Gabapentin—migraine	0.000204	0.00598	CcSEcCtD
Metipranolol—Bradycardia—Timolol—migraine	0.000203	0.00596	CcSEcCtD
Metipranolol—Myocardial infarction—Gabapentin—migraine	0.000203	0.00595	CcSEcCtD
Metipranolol—Conjunctivitis—Gabapentin—migraine	0.000201	0.0059	CcSEcCtD
Metipranolol—Dyspnoea—Verapamil—migraine	0.0002	0.00587	CcSEcCtD
Metipranolol—Rhinitis—Timolol—migraine	0.0002	0.00587	CcSEcCtD
Metipranolol—Somnolence—Verapamil—migraine	0.0002	0.00586	CcSEcCtD
Metipranolol—Propranolol—HTR1B—migraine	0.000199	0.148	CrCbGaD
Metipranolol—Dizziness—Amitriptyline—migraine	0.000198	0.00582	CcSEcCtD
Metipranolol—Epistaxis—Gabapentin—migraine	0.000195	0.00573	CcSEcCtD
Metipranolol—Visual impairment—Timolol—migraine	0.000192	0.00564	CcSEcCtD
Metipranolol—Tension—Valproic Acid—migraine	0.000192	0.00562	CcSEcCtD
Metipranolol—Angina pectoris—Topiramate—migraine	0.00019	0.00558	CcSEcCtD
Metipranolol—Nervousness—Valproic Acid—migraine	0.00019	0.00556	CcSEcCtD
Metipranolol—Bradycardia—Gabapentin—migraine	0.000189	0.00555	CcSEcCtD
Metipranolol—Rash—Amitriptyline—migraine	0.000189	0.00555	CcSEcCtD
Metipranolol—Dermatitis—Amitriptyline—migraine	0.000189	0.00554	CcSEcCtD
Metipranolol—Headache—Amitriptyline—migraine	0.000188	0.00551	CcSEcCtD
Metipranolol—Bronchitis—Topiramate—migraine	0.000188	0.00551	CcSEcCtD
Metipranolol—Rhinitis—Gabapentin—migraine	0.000186	0.00546	CcSEcCtD
Metipranolol—ADRB2—GPCRs, Other—EDNRA—migraine	0.000184	0.00693	CbGpPWpGaD
Metipranolol—Vision blurred—Valproic Acid—migraine	0.000184	0.00539	CcSEcCtD
Metipranolol—Hypersensitivity—Propranolol—migraine	0.00018	0.00528	CcSEcCtD
Metipranolol—Visual impairment—Gabapentin—migraine	0.000179	0.00525	CcSEcCtD
Metipranolol—Nausea—Amitriptyline—migraine	0.000178	0.00522	CcSEcCtD
Metipranolol—Asthenia—Propranolol—migraine	0.000175	0.00514	CcSEcCtD
Metipranolol—Palpitations—Valproic Acid—migraine	0.000173	0.00506	CcSEcCtD
Metipranolol—Tension—Timolol—migraine	0.000171	0.005	CcSEcCtD
Metipranolol—Cough—Valproic Acid—migraine	0.00017	0.00499	CcSEcCtD
Metipranolol—Conjunctivitis—Topiramate—migraine	0.000169	0.00496	CcSEcCtD
Metipranolol—Nervousness—Timolol—migraine	0.000169	0.00495	CcSEcCtD
Metipranolol—Hypertension—Valproic Acid—migraine	0.000169	0.00494	CcSEcCtD
Metipranolol—Myalgia—Valproic Acid—migraine	0.000166	0.00487	CcSEcCtD
Metipranolol—ADRB2—GPCRs, Other—HTR7—migraine	0.000166	0.00624	CbGpPWpGaD
Metipranolol—Anxiety—Valproic Acid—migraine	0.000166	0.00486	CcSEcCtD
Metipranolol—Hypersensitivity—Verapamil—migraine	0.000166	0.00485	CcSEcCtD
Metipranolol—Epistaxis—Topiramate—migraine	0.000164	0.00482	CcSEcCtD
Metipranolol—Discomfort—Valproic Acid—migraine	0.000164	0.00481	CcSEcCtD
Metipranolol—Vision blurred—Timolol—migraine	0.000164	0.0048	CcSEcCtD
Metipranolol—Dizziness—Propranolol—migraine	0.000162	0.00474	CcSEcCtD
Metipranolol—Asthenia—Verapamil—migraine	0.000161	0.00473	CcSEcCtD
Metipranolol—Oedema—Valproic Acid—migraine	0.000159	0.00467	CcSEcCtD
Metipranolol—Bradycardia—Topiramate—migraine	0.000159	0.00467	CcSEcCtD
Metipranolol—Tension—Gabapentin—migraine	0.000159	0.00466	CcSEcCtD
Metipranolol—Propranolol—HTR1A—migraine	0.000157	0.117	CrCbGaD
Metipranolol—Nervousness—Gabapentin—migraine	0.000157	0.00461	CcSEcCtD
Metipranolol—Rhinitis—Topiramate—migraine	0.000157	0.0046	CcSEcCtD
Metipranolol—ADRB1—G alpha (s) signalling events—NPS—migraine	0.000154	0.0058	CbGpPWpGaD
Metipranolol—Rash—Propranolol—migraine	0.000154	0.00452	CcSEcCtD
Metipranolol—Dermatitis—Propranolol—migraine	0.000154	0.00451	CcSEcCtD
Metipranolol—Palpitations—Timolol—migraine	0.000154	0.0045	CcSEcCtD
Metipranolol—Vision blurred—Gabapentin—migraine	0.000153	0.00447	CcSEcCtD
Metipranolol—Cough—Timolol—migraine	0.000152	0.00445	CcSEcCtD
Metipranolol—ADRB2—G alpha (s) signalling events—NPS—migraine	0.000151	0.00567	CbGpPWpGaD
Metipranolol—Visual impairment—Topiramate—migraine	0.000151	0.00442	CcSEcCtD
Metipranolol—Hypertension—Timolol—migraine	0.00015	0.0044	CcSEcCtD
Metipranolol—ADRB1—GPCRs, Class A Rhodopsin-like—HTR1D—migraine	0.000149	0.00562	CbGpPWpGaD
Metipranolol—Dizziness—Verapamil—migraine	0.000149	0.00436	CcSEcCtD
Metipranolol—Myalgia—Timolol—migraine	0.000148	0.00434	CcSEcCtD
Metipranolol—Anxiety—Timolol—migraine	0.000147	0.00432	CcSEcCtD
Metipranolol—Discomfort—Timolol—migraine	0.000146	0.00429	CcSEcCtD
Metipranolol—ADRB2—GPCRs, Class A Rhodopsin-like—HTR1D—migraine	0.000146	0.0055	CbGpPWpGaD
Metipranolol—Musculoskeletal discomfort—Valproic Acid—migraine	0.000145	0.00426	CcSEcCtD
Metipranolol—Nausea—Propranolol—migraine	0.000145	0.00425	CcSEcCtD
Metipranolol—Palpitations—Gabapentin—migraine	0.000143	0.00419	CcSEcCtD
Metipranolol—Dyspnoea—Valproic Acid—migraine	0.000142	0.00416	CcSEcCtD
Metipranolol—Oedema—Timolol—migraine	0.000142	0.00416	CcSEcCtD
Metipranolol—Rash—Verapamil—migraine	0.000142	0.00415	CcSEcCtD
Metipranolol—Somnolence—Valproic Acid—migraine	0.000142	0.00415	CcSEcCtD
Metipranolol—Dermatitis—Verapamil—migraine	0.000142	0.00415	CcSEcCtD
Metipranolol—ADRB1—G alpha (s) signalling events—CALCA—migraine	0.000142	0.00533	CbGpPWpGaD
Metipranolol—Cough—Gabapentin—migraine	0.000141	0.00414	CcSEcCtD
Metipranolol—Headache—Verapamil—migraine	0.000141	0.00413	CcSEcCtD
Metipranolol—Hypertension—Gabapentin—migraine	0.00014	0.0041	CcSEcCtD
Metipranolol—ADRB1—GPCRs, Class A Rhodopsin-like—HTR2B—migraine	0.000139	0.00522	CbGpPWpGaD
Metipranolol—ADRB2—G alpha (s) signalling events—CALCA—migraine	0.000138	0.00521	CbGpPWpGaD
Metipranolol—Myalgia—Gabapentin—migraine	0.000138	0.00404	CcSEcCtD
Metipranolol—Anxiety—Gabapentin—migraine	0.000137	0.00403	CcSEcCtD
Metipranolol—Discomfort—Gabapentin—migraine	0.000136	0.00399	CcSEcCtD
Metipranolol—ADRB2—GPCRs, Class A Rhodopsin-like—HTR2B—migraine	0.000136	0.00511	CbGpPWpGaD
Metipranolol—ADRB1—GPCR ligand binding—RAMP1—migraine	0.000134	0.00505	CbGpPWpGaD
Metipranolol—ADRB1—GPCR ligand binding—CALCRL—migraine	0.000134	0.00505	CbGpPWpGaD
Metipranolol—Tension—Topiramate—migraine	0.000134	0.00392	CcSEcCtD
Metipranolol—Nausea—Verapamil—migraine	0.000133	0.00391	CcSEcCtD
Metipranolol—ADRB1—G alpha (s) signalling events—HTR7—migraine	0.000132	0.00498	CbGpPWpGaD
Metipranolol—Nervousness—Topiramate—migraine	0.000132	0.00388	CcSEcCtD
Metipranolol—Oedema—Gabapentin—migraine	0.000132	0.00387	CcSEcCtD
Metipranolol—ADRB2—GPCR ligand binding—RAMP1—migraine	0.000131	0.00494	CbGpPWpGaD
Metipranolol—ADRB2—GPCR ligand binding—CALCRL—migraine	0.000131	0.00494	CbGpPWpGaD
Metipranolol—ADRB2—G alpha (s) signalling events—HTR7—migraine	0.000129	0.00487	CbGpPWpGaD
Metipranolol—Musculoskeletal discomfort—Timolol—migraine	0.000129	0.00379	CcSEcCtD
Metipranolol—Vision blurred—Topiramate—migraine	0.000128	0.00376	CcSEcCtD
Metipranolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR1D—migraine	0.000128	0.00481	CbGpPWpGaD
Metipranolol—Dyspnoea—Timolol—migraine	0.000126	0.00371	CcSEcCtD
Metipranolol—Somnolence—Timolol—migraine	0.000126	0.0037	CcSEcCtD
Metipranolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR1D—migraine	0.000125	0.00471	CbGpPWpGaD
Metipranolol—Musculoskeletal discomfort—Gabapentin—migraine	0.00012	0.00353	CcSEcCtD
Metipranolol—Palpitations—Topiramate—migraine	0.00012	0.00353	CcSEcCtD
Metipranolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR2B—migraine	0.000119	0.00448	CbGpPWpGaD
Metipranolol—Cough—Topiramate—migraine	0.000119	0.00348	CcSEcCtD
Metipranolol—Dyspnoea—Gabapentin—migraine	0.000118	0.00345	CcSEcCtD
Metipranolol—Hypertension—Topiramate—migraine	0.000118	0.00345	CcSEcCtD
Metipranolol—Somnolence—Gabapentin—migraine	0.000117	0.00344	CcSEcCtD
Metipranolol—Hypersensitivity—Valproic Acid—migraine	0.000117	0.00344	CcSEcCtD
Metipranolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR2B—migraine	0.000116	0.00438	CbGpPWpGaD
Metipranolol—ADRB2—GPCRs, Other—HTR2A—migraine	0.000116	0.00437	CbGpPWpGaD
Metipranolol—Myalgia—Topiramate—migraine	0.000116	0.0034	CcSEcCtD
Metipranolol—Anxiety—Topiramate—migraine	0.000116	0.00339	CcSEcCtD
Metipranolol—Discomfort—Topiramate—migraine	0.000115	0.00336	CcSEcCtD
Metipranolol—Asthenia—Valproic Acid—migraine	0.000114	0.00335	CcSEcCtD
Metipranolol—Oedema—Topiramate—migraine	0.000111	0.00326	CcSEcCtD
Metipranolol—Dizziness—Valproic Acid—migraine	0.000105	0.00309	CcSEcCtD
Metipranolol—Hypersensitivity—Timolol—migraine	0.000104	0.00306	CcSEcCtD
Metipranolol—Asthenia—Timolol—migraine	0.000102	0.00298	CcSEcCtD
Metipranolol—Musculoskeletal discomfort—Topiramate—migraine	0.000101	0.00297	CcSEcCtD
Metipranolol—Rash—Valproic Acid—migraine	0.0001	0.00295	CcSEcCtD
Metipranolol—Dermatitis—Valproic Acid—migraine	0.0001	0.00294	CcSEcCtD
Metipranolol—Headache—Valproic Acid—migraine	9.98e-05	0.00293	CcSEcCtD
Metipranolol—Dyspnoea—Topiramate—migraine	9.91e-05	0.0029	CcSEcCtD
Metipranolol—Somnolence—Topiramate—migraine	9.88e-05	0.0029	CcSEcCtD
Metipranolol—ADRB1—GPCR ligand binding—HTR1D—migraine	9.74e-05	0.00367	CbGpPWpGaD
Metipranolol—Hypersensitivity—Gabapentin—migraine	9.73e-05	0.00285	CcSEcCtD
Metipranolol—ADRB2—GPCR ligand binding—HTR1D—migraine	9.53e-05	0.00359	CbGpPWpGaD
Metipranolol—Asthenia—Gabapentin—migraine	9.48e-05	0.00278	CcSEcCtD
Metipranolol—Nausea—Valproic Acid—migraine	9.46e-05	0.00277	CcSEcCtD
Metipranolol—Dizziness—Timolol—migraine	9.38e-05	0.00275	CcSEcCtD
Metipranolol—ADRB1—GPCR ligand binding—HTR2B—migraine	9.06e-05	0.00341	CbGpPWpGaD
Metipranolol—ADRB1—GPCRs, Class A Rhodopsin-like—HTR1B—migraine	9.05e-05	0.0034	CbGpPWpGaD
Metipranolol—Rash—Timolol—migraine	8.94e-05	0.00262	CcSEcCtD
Metipranolol—Dermatitis—Timolol—migraine	8.93e-05	0.00262	CcSEcCtD
Metipranolol—Headache—Timolol—migraine	8.88e-05	0.0026	CcSEcCtD
Metipranolol—ADRB2—GPCR ligand binding—HTR2B—migraine	8.86e-05	0.00333	CbGpPWpGaD
Metipranolol—ADRB2—GPCRs, Class A Rhodopsin-like—HTR1B—migraine	8.85e-05	0.00333	CbGpPWpGaD
Metipranolol—Dizziness—Gabapentin—migraine	8.73e-05	0.00256	CcSEcCtD
Metipranolol—ADRB1—GPCRs, Class A Rhodopsin-like—HTR1A—migraine	8.71e-05	0.00328	CbGpPWpGaD
Metipranolol—ADRB2—GPCRs, Class A Rhodopsin-like—HTR1A—migraine	8.52e-05	0.00321	CbGpPWpGaD
Metipranolol—Nausea—Timolol—migraine	8.42e-05	0.00247	CcSEcCtD
Metipranolol—ADRB1—GPCRs, Class A Rhodopsin-like—HTR2C—migraine	8.41e-05	0.00317	CbGpPWpGaD
Metipranolol—Rash—Gabapentin—migraine	8.33e-05	0.00244	CcSEcCtD
Metipranolol—Dermatitis—Gabapentin—migraine	8.32e-05	0.00244	CcSEcCtD
Metipranolol—Headache—Gabapentin—migraine	8.27e-05	0.00243	CcSEcCtD
Metipranolol—ADRB2—GPCRs, Class A Rhodopsin-like—HTR2C—migraine	8.23e-05	0.0031	CbGpPWpGaD
Metipranolol—Hypersensitivity—Topiramate—migraine	8.19e-05	0.0024	CcSEcCtD
Metipranolol—ADRB1—GPCRs, Class A Rhodopsin-like—EDNRA—migraine	8.18e-05	0.00308	CbGpPWpGaD
Metipranolol—ADRB2—GPCRs, Class A Rhodopsin-like—EDNRA—migraine	8e-05	0.00301	CbGpPWpGaD
Metipranolol—Asthenia—Topiramate—migraine	7.97e-05	0.00234	CcSEcCtD
Metipranolol—Nausea—Gabapentin—migraine	7.84e-05	0.0023	CcSEcCtD
Metipranolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR1B—migraine	7.75e-05	0.00292	CbGpPWpGaD
Metipranolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR1B—migraine	7.58e-05	0.00285	CbGpPWpGaD
Metipranolol—ADRB1—GPCR downstream signaling—RAMP1—migraine	7.58e-05	0.00285	CbGpPWpGaD
Metipranolol—ADRB1—GPCR downstream signaling—CALCRL—migraine	7.58e-05	0.00285	CbGpPWpGaD
Metipranolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR1A—migraine	7.46e-05	0.00281	CbGpPWpGaD
Metipranolol—ADRB2—GPCR downstream signaling—RAMP1—migraine	7.41e-05	0.00279	CbGpPWpGaD
Metipranolol—ADRB2—GPCR downstream signaling—CALCRL—migraine	7.41e-05	0.00279	CbGpPWpGaD
Metipranolol—ADRB1—GPCRs, Class A Rhodopsin-like—HTR7—migraine	7.37e-05	0.00277	CbGpPWpGaD
Metipranolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—TAC1—migraine	7.35e-05	0.00277	CbGpPWpGaD
Metipranolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—NPS—migraine	7.35e-05	0.00277	CbGpPWpGaD
Metipranolol—Dizziness—Topiramate—migraine	7.35e-05	0.00215	CcSEcCtD
Metipranolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR1A—migraine	7.3e-05	0.00275	CbGpPWpGaD
Metipranolol—ADRB2—GPCRs, Class A Rhodopsin-like—HTR7—migraine	7.21e-05	0.00271	CbGpPWpGaD
Metipranolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR2C—migraine	7.21e-05	0.00271	CbGpPWpGaD
Metipranolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—NPS—migraine	7.19e-05	0.00271	CbGpPWpGaD
Metipranolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—TAC1—migraine	7.19e-05	0.00271	CbGpPWpGaD
Metipranolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR2C—migraine	7.05e-05	0.00265	CbGpPWpGaD
Metipranolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—EDNRA—migraine	7.01e-05	0.00264	CbGpPWpGaD
Metipranolol—Rash—Topiramate—migraine	7.01e-05	0.00205	CcSEcCtD
Metipranolol—Dermatitis—Topiramate—migraine	7e-05	0.00205	CcSEcCtD
Metipranolol—Headache—Topiramate—migraine	6.96e-05	0.00204	CcSEcCtD
Metipranolol—ADRB1—Signaling by GPCR—RAMP1—migraine	6.88e-05	0.00259	CbGpPWpGaD
Metipranolol—ADRB1—Signaling by GPCR—CALCRL—migraine	6.88e-05	0.00259	CbGpPWpGaD
Metipranolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—EDNRA—migraine	6.86e-05	0.00258	CbGpPWpGaD
Metipranolol—ADRB2—Signaling by GPCR—RAMP1—migraine	6.73e-05	0.00253	CbGpPWpGaD
Metipranolol—ADRB2—Signaling by GPCR—CALCRL—migraine	6.73e-05	0.00253	CbGpPWpGaD
Metipranolol—Nausea—Topiramate—migraine	6.6e-05	0.00193	CcSEcCtD
Metipranolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR7—migraine	6.31e-05	0.00238	CbGpPWpGaD
Metipranolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR7—migraine	6.17e-05	0.00232	CbGpPWpGaD
Metipranolol—ADRB1—GPCR ligand binding—HTR1B—migraine	5.9e-05	0.00222	CbGpPWpGaD
Metipranolol—ADRB2—GPCR ligand binding—HTR1B—migraine	5.77e-05	0.00217	CbGpPWpGaD
Metipranolol—ADRB1—GPCR ligand binding—HTR1A—migraine	5.68e-05	0.00214	CbGpPWpGaD
Metipranolol—ADRB1—GPCR ligand binding—NPS—migraine	5.6e-05	0.00211	CbGpPWpGaD
Metipranolol—ADRB1—GPCR ligand binding—TAC1—migraine	5.6e-05	0.00211	CbGpPWpGaD
Metipranolol—ADRB2—GPCR ligand binding—HTR1A—migraine	5.56e-05	0.00209	CbGpPWpGaD
Metipranolol—ADRB1—GPCR downstream signaling—HTR1D—migraine	5.51e-05	0.00207	CbGpPWpGaD
Metipranolol—ADRB1—GPCR ligand binding—HTR2C—migraine	5.49e-05	0.00207	CbGpPWpGaD
Metipranolol—ADRB2—GPCR ligand binding—NPS—migraine	5.47e-05	0.00206	CbGpPWpGaD
Metipranolol—ADRB2—GPCR ligand binding—TAC1—migraine	5.47e-05	0.00206	CbGpPWpGaD
Metipranolol—ADRB2—GPCR downstream signaling—HTR1D—migraine	5.39e-05	0.00203	CbGpPWpGaD
Metipranolol—ADRB2—GPCR ligand binding—HTR2C—migraine	5.37e-05	0.00202	CbGpPWpGaD
Metipranolol—ADRB1—GPCR ligand binding—EDNRA—migraine	5.34e-05	0.00201	CbGpPWpGaD
Metipranolol—ADRB2—GPCR ligand binding—EDNRA—migraine	5.22e-05	0.00197	CbGpPWpGaD
Metipranolol—ADRB1—GPCRs, Class A Rhodopsin-like—HTR2A—migraine	5.16e-05	0.00194	CbGpPWpGaD
Metipranolol—ADRB1—GPCR ligand binding—CALCA—migraine	5.14e-05	0.00193	CbGpPWpGaD
Metipranolol—ADRB1—GPCR downstream signaling—HTR2B—migraine	5.12e-05	0.00193	CbGpPWpGaD
Metipranolol—ADRB2—GPCRs, Class A Rhodopsin-like—HTR2A—migraine	5.05e-05	0.0019	CbGpPWpGaD
Metipranolol—ADRB2—GPCR ligand binding—CALCA—migraine	5.03e-05	0.00189	CbGpPWpGaD
Metipranolol—ADRB2—GPCR downstream signaling—HTR2B—migraine	5.01e-05	0.00188	CbGpPWpGaD
Metipranolol—ADRB1—Signaling by GPCR—HTR1D—migraine	5e-05	0.00188	CbGpPWpGaD
Metipranolol—ADRB2—Signaling by GPCR—HTR1D—migraine	4.89e-05	0.00184	CbGpPWpGaD
Metipranolol—ADRB1—GPCR ligand binding—HTR7—migraine	4.81e-05	0.00181	CbGpPWpGaD
Metipranolol—ADRB2—GPCR ligand binding—HTR7—migraine	4.7e-05	0.00177	CbGpPWpGaD
Metipranolol—ADRB1—Signaling by GPCR—HTR2B—migraine	4.65e-05	0.00175	CbGpPWpGaD
Metipranolol—ADRB2—Signaling by GPCR—HTR2B—migraine	4.55e-05	0.00171	CbGpPWpGaD
Metipranolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR2A—migraine	4.42e-05	0.00166	CbGpPWpGaD
Metipranolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR2A—migraine	4.32e-05	0.00163	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—CALCRL—migraine	4.06e-05	0.00153	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—RAMP1—migraine	4.06e-05	0.00153	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—RAMP1—migraine	3.98e-05	0.0015	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—CALCRL—migraine	3.98e-05	0.0015	CbGpPWpGaD
Metipranolol—ADRB1—GPCR ligand binding—HTR2A—migraine	3.37e-05	0.00127	CbGpPWpGaD
Metipranolol—ADRB1—GPCR downstream signaling—HTR1B—migraine	3.34e-05	0.00126	CbGpPWpGaD
Metipranolol—ADRB2—GPCR ligand binding—HTR2A—migraine	3.29e-05	0.00124	CbGpPWpGaD
Metipranolol—ADRB2—GPCR downstream signaling—HTR1B—migraine	3.26e-05	0.00123	CbGpPWpGaD
Metipranolol—ADRB1—GPCR downstream signaling—HTR1A—migraine	3.21e-05	0.00121	CbGpPWpGaD
Metipranolol—ADRB1—GPCR downstream signaling—NPS—migraine	3.16e-05	0.00119	CbGpPWpGaD
Metipranolol—ADRB1—GPCR downstream signaling—TAC1—migraine	3.16e-05	0.00119	CbGpPWpGaD
Metipranolol—ADRB2—GPCR downstream signaling—HTR1A—migraine	3.14e-05	0.00118	CbGpPWpGaD
Metipranolol—ADRB1—GPCR downstream signaling—HTR2C—migraine	3.1e-05	0.00117	CbGpPWpGaD
Metipranolol—ADRB2—GPCR downstream signaling—TAC1—migraine	3.09e-05	0.00116	CbGpPWpGaD
Metipranolol—ADRB2—GPCR downstream signaling—NPS—migraine	3.09e-05	0.00116	CbGpPWpGaD
Metipranolol—ADRB2—GPCR downstream signaling—HTR2C—migraine	3.03e-05	0.00114	CbGpPWpGaD
Metipranolol—ADRB1—Signaling by GPCR—HTR1B—migraine	3.03e-05	0.00114	CbGpPWpGaD
Metipranolol—ADRB1—GPCR downstream signaling—EDNRA—migraine	3.02e-05	0.00114	CbGpPWpGaD
Metipranolol—ADRB2—Signaling by GPCR—HTR1B—migraine	2.96e-05	0.00112	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—HTR1D—migraine	2.95e-05	0.00111	CbGpPWpGaD
Metipranolol—ADRB2—GPCR downstream signaling—EDNRA—migraine	2.95e-05	0.00111	CbGpPWpGaD
Metipranolol—ADRB1—Signaling by GPCR—HTR1A—migraine	2.92e-05	0.0011	CbGpPWpGaD
Metipranolol—ADRB1—GPCR downstream signaling—CALCA—migraine	2.9e-05	0.00109	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—HTR1D—migraine	2.89e-05	0.00109	CbGpPWpGaD
Metipranolol—ADRB1—Signaling by GPCR—TAC1—migraine	2.87e-05	0.00108	CbGpPWpGaD
Metipranolol—ADRB1—Signaling by GPCR—NPS—migraine	2.87e-05	0.00108	CbGpPWpGaD
Metipranolol—ADRB2—Signaling by GPCR—HTR1A—migraine	2.85e-05	0.00107	CbGpPWpGaD
Metipranolol—ADRB2—GPCR downstream signaling—CALCA—migraine	2.84e-05	0.00107	CbGpPWpGaD
Metipranolol—ADRB1—Signaling by GPCR—HTR2C—migraine	2.82e-05	0.00106	CbGpPWpGaD
Metipranolol—ADRB2—Signaling by GPCR—TAC1—migraine	2.81e-05	0.00106	CbGpPWpGaD
Metipranolol—ADRB2—Signaling by GPCR—NPS—migraine	2.81e-05	0.00106	CbGpPWpGaD
Metipranolol—ADRB2—Signaling by GPCR—HTR2C—migraine	2.75e-05	0.00104	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—HTR2B—migraine	2.75e-05	0.00103	CbGpPWpGaD
Metipranolol—ADRB1—Signaling by GPCR—EDNRA—migraine	2.74e-05	0.00103	CbGpPWpGaD
Metipranolol—ADRB1—GPCR downstream signaling—HTR7—migraine	2.72e-05	0.00102	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—HTR2B—migraine	2.69e-05	0.00101	CbGpPWpGaD
Metipranolol—ADRB2—Signaling by GPCR—EDNRA—migraine	2.68e-05	0.00101	CbGpPWpGaD
Metipranolol—ADRB2—GPCR downstream signaling—HTR7—migraine	2.66e-05	0.001	CbGpPWpGaD
Metipranolol—ADRB1—Signaling by GPCR—CALCA—migraine	2.64e-05	0.000992	CbGpPWpGaD
Metipranolol—ADRB2—Signaling by GPCR—CALCA—migraine	2.58e-05	0.000971	CbGpPWpGaD
Metipranolol—ADRB1—Signaling by GPCR—HTR7—migraine	2.47e-05	0.000928	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—LRP1—migraine	2.42e-05	0.00091	CbGpPWpGaD
Metipranolol—ADRB2—Signaling by GPCR—HTR7—migraine	2.41e-05	0.000908	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—LRP1—migraine	2.36e-05	0.00089	CbGpPWpGaD
Metipranolol—ADRB1—GPCR downstream signaling—HTR2A—migraine	1.9e-05	0.000716	CbGpPWpGaD
Metipranolol—ADRB2—GPCR downstream signaling—HTR2A—migraine	1.86e-05	0.0007	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—NOTCH4—migraine	1.85e-05	0.000698	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—NOTCH4—migraine	1.81e-05	0.000683	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—HTR1B—migraine	1.79e-05	0.000673	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—HTR1B—migraine	1.75e-05	0.000659	CbGpPWpGaD
Metipranolol—ADRB1—Signaling by GPCR—HTR2A—migraine	1.73e-05	0.00065	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—HTR1A—migraine	1.72e-05	0.000648	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—PGR—migraine	1.7e-05	0.000638	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—TAC1—migraine	1.7e-05	0.000638	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—NPS—migraine	1.7e-05	0.000638	CbGpPWpGaD
Metipranolol—ADRB2—Signaling by GPCR—HTR2A—migraine	1.69e-05	0.000636	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—HTR1A—migraine	1.68e-05	0.000634	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—HTR2C—migraine	1.66e-05	0.000626	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—TAC1—migraine	1.66e-05	0.000624	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—PGR—migraine	1.66e-05	0.000624	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—NPS—migraine	1.66e-05	0.000624	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—HTR2C—migraine	1.63e-05	0.000612	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—EDNRA—migraine	1.62e-05	0.000609	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—EDNRA—migraine	1.58e-05	0.000596	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—NOTCH3—migraine	1.58e-05	0.000593	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—CALCA—migraine	1.56e-05	0.000586	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—NOTCH3—migraine	1.54e-05	0.000581	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—CALCA—migraine	1.52e-05	0.000573	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—HTR7—migraine	1.46e-05	0.000548	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—HTR7—migraine	1.43e-05	0.000536	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—TGFBR2—migraine	1.25e-05	0.000472	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—TGFBR2—migraine	1.23e-05	0.000462	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—HTR2A—migraine	1.02e-05	0.000384	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—HTR2A—migraine	9.98e-06	0.000376	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—ESR1—migraine	9.06e-06	0.000341	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—ESR1—migraine	8.86e-06	0.000333	CbGpPWpGaD
